GLOW

What is GLOW?

GLOW is the name of a combined research preparation. The declared composition is shown in the table.

The total declared content is 70 mg. GLOW is not the name of a single peptide nor a standardized scientific designation: the composition of products with this name may vary among suppliers.

Composition and total content

Quantities indicate the total declared content of the package, not the concentration or quantity per application. Research on the components does not prove synergy or properties of the finished mixture.

Mechanism and scientific context

The components of the GLOW preparation are studied separately in various experimental systems:

GHK-Cu is a complex of the tripeptide glycyl-L-histidyl-L-lysine with copper. It is studied in the context of cell signaling, extracellular matrix, and tissue response to damage.

BPC-157 is a synthetic peptide of 15 amino acids. Its research primarily covers preclinical models of tissue response, vascular biology, and signaling processes related to damage.

TB-500 is a name used in commercial offers for materials related to thymosin beta-4. The exact identity and sequence must be verified in the batch documentation. Research on intact thymosin beta-4, including its role in actin binding and cell migration, cannot be automatically attributed to every product labeled as TB-500.

Combined packaging does not prove synergistic action. The properties of the mixture, including stability, component interactions, and biological activity, require separate verification.

Main research areas

• cell migration and response to damage
• extracellular matrix and tissue remodeling
• vascular and epithelial biology
• signaling processes related to peptides and copper
• compatibility and stability of multi-component preparations

The listed areas primarily describe the research context of individual components, not confirmed effects of the GLOW combination.

How to interpret research data?

Literature should be read according to the exact component, formulation, and type of evidence. Results from biochemical analyses, cell cultures, animal models, and controlled clinical studies do not carry equal weight.

Research on an individual peptide is not research on the combination of GHK-Cu, BPC-157, and TB-500 in a 50:10:10 mg ratio. Similarly, data on local or cosmetic formulations do not confirm the safety of other formulations or routes of administration.

To evaluate a combination, the identity and quantity of each component, the composition of the solution, concentration, storage conditions, duration of observation, and independent reproducibility of results are important.

Available Peptiva variants

• 70 mg · Vial
• 70 mg · Research dispenser

Both variants have a declared composition of GHK-Cu 50 mg, BPC-157 10 mg, and TB-500 10 mg. You choose the available format as a variant of the same product. Before ordering, check the selected variant and its corresponding price.

Format and packaging content

Research dispenser: The variant contains a complete pre-filled dispenser with the selected content, not just a separate refill cartridge. The quantity listed with the variant refers to the total declared content, not the quantity per individual use.

Vial: The variant contains the combined research material in a vial, without a dispenser. The packaging name itself does not determine whether the content is lyophilized, in another solid form, or in solution; the declaration of the specific batch is authoritative. This description does not refer to bacteriostatic water or a separate empty container.

The 70 mg label represents the sum of the declared quantities of the three components. It does not represent the quantity of each individual peptide nor the concentration in mg/ml. The GHK-Cu 50 mg label refers to the declared quantity of the complex, not 50 mg of elemental copper.

Storage and handling conditions depend on the specific formulation and batch declaration. The packaging form does not confirm sterility, dosing precision, stability, or suitability for human or animal use.

Important limitations

Clinical confirmed safety, efficacy, or synergy should not be assumed for this combination. Data on individual components do not confirm the properties of the finished mixture.

The product is not intended for skin rejuvenation, wound or injury treatment, hair growth stimulation, improvement of athletic recovery, or self-administration. The name GLOW is not a promise of aesthetic or health effects.

Batch documentation

For inquiries about available COA documentation, please contact peptivacomhr@gmail.com with the product name and LOT number if known. Availability and scope of analyses are checked for the specific batch.

For combined preparations, it is important to distinguish between analyses of individual raw materials and analyses of the finished mixture. Confirmation of the purity of one component does not confirm the identity, quantity, or stability of all components in the final product.

COA itself does not prove biological activity, absence of endotoxins, sterility, or suitability for human or animal use.

Purpose and limitations: The product is intended exclusively for laboratory research. It is not intended for use in humans or animals, diagnosis, treatment, mitigation, or prevention of diseases. The description is not medical advice. The research-use-only designation and packaging name themselves do not determine the regulatory status of the product nor prove its safety or sterility.